GlassScriptPhysician profile
Arthur W Nauman
NPI 1083777379
$3,155.79
in general payments reported to CMS, 2019-2025
25 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $103 · 2021: $364 · 2022: $774 · 2023: $741 · 2024: $508 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,169 · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.94 |
| Education | $210.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $800.31 | 2019-2024 | |
| Astellas Pharma US INC | $642.68 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $631.48 | 2021-2025 | |
| Therapeuticsmd, INC. | $181.70 | 2019-2022 | |
| Coopersurgical, INC. | $175.30 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Amag Pharmaceuticals, INC. | $126.90 | 2019 | |
| Aspira Women'S Health INC | $80.81 | 2022-2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $71.97 | 2019-2023 | |
| Myovant Sciences INC. | $61.11 | 2022 | |
| Exeltis, USA INC. | $60.86 | 2022-2023 | Slynd |
| Sage Therapeutics, LLC | $46.30 | 2019-2024 | |
| Organon LLC | $35.92 | 2022 | |
| Scynexis, INC. | $31.45 | 2022 | |
| Pfizer INC. | $30.08 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $29.82 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $26.70 | 2024 | |
| Evofem Biosciences, INC. | $15.98 | 2022 | |
| Avion Pharmaceuticals | $14.55 | 2022 | |
| Duchesnay USA Incorporated | $13.91 | 2019 | |
| Roche Diagnostics Corporation | $13.83 | 2019 | |
| Dysis Medical, INC. | $13.77 | 2019 | |
| Lupin INC. | $13.68 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.45 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $11.84 | 2022 | |
| Horizon Therapeutics Plc | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Nauman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.